Pacific biosciences of california stock.

Find the latest Pacific Biosciences of California, Inc. (PACB) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Pacific Biosciences of California's (PACB) CEO Mike Hunkapiller on Q4 2015 Results - Earnings Call Transcript SA Transcripts Wed, Feb. 03, 2016 Pacific Biosciences of California (PACB) Q4 2015 ...Pacific Biosciences of California Stock Up 2.3 %. Shares of NASDAQ:PACB opened at $8.55 on Friday. The company has a debt-to-equity ratio of 1.17, a current ratio of 4.80 and a quick ratio of 4.43.Get Pacific Biosciences of California (PACB) share price today, stock analysis, price valuation, performance, fundamentals, market cap, shareholding, ...Pacific Biosciences of California (PACB) Reports Q2 Loss, Tops Revenue Estimates. by Zacks Equity Research Published on August 02,2023. Pacific Biosciences (PACB) delivered earnings and revenue ...

RIP to These 3 Dying Medical Stocks. PACB – Since the high inflation is leading to rising healthcare spending, it could be wise to sell fundamentally weak medical stocks, Pacific Biosciences (PACB), DermTech (DMTK), and Genetic Technologies (GENE), before things get even uglier. Continue reading…. While investors anticipate the …Sep 18, 2023 · One such stock that merits attention is Pacific Biosciences of California Inc (NASDAQ:PACB). The stock, which is currently priced at 10.06, recorded a loss of 3.5% in a day and a 3-month decrease ... Find the latest Pacific Biosciences of California, Inc. (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. Home. Mail; Search; News; Finance; ... Pacific Biosciences of California, Inc. (PACB) NasdaqGS - NasdaqGS Real-time price. Currency in USD. Add to watchlist. 8.88 +0.40 (+4.72%)

Find the latest Pacific Biosciences of California, Inc. (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing.

Pacific Biosciences of California Inc’s ( PACB) price is currently down 20.92% so far this month. During the month of February, Pacific Biosciences of California Inc’s stock price has reached a high of $12.35 and a low of $8.71. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as …You can hold this stock in a SIPP, ISA, JISA and Trading Account. Market Cap. $2.030bn. Div. Yield. -. Volume. 6,012,760. Open Price. $8.49. Prev. Close. $8.58.Nov 17, 2023 · Pacific Biosciences of California Inc’s Stock Price as of Market Close As of November 17, 2023, 4:00 PM, CST, Pacific Biosciences of California Inc’s stock price was $8.40. Pacific Biosciences of California Inc is up 10.67% from its previous closing price of $7.59. Complete Pacific Biosciences of California Inc. stock information by Barron's. View real-time PACB stock price and news, along with industry-best analysis. Stocks of Pacific Biosciences of California Inc saw a sharp rise in short interest on Nov 14, 2023 jumping by 1.49 million shares to 39.23 million. Data from Yahoo Finance shows that the short interest on Oct 12, 2023 was 37.74 million shares. A jump of 3.8% in short interest reflects a negative sentiment towards the stock.

Pacific Biosciences of California (NASDAQ:PACB) rose 3.16% Friday pre-market after UBS upgraded the sequencing systems company on a strong "Revio" demand. ... The stock is currently trading at $7. ...

On average, Wall Street analysts predict. that Pacific Biosciences Of California's share price could reach $10.57 by Nov 17, 2024. The average Pacific Biosciences Of California stock price prediction forecasts a potential upside of …

PacBio highly accurate long-read sequencing provides the most comprehensive view of genomes, transcriptomes, and epigenomes. Learn how SMRT sequencing powers genomic insights in humans, plants, animals and microbes.The Pacific Biosciences of California stock prediction results are shown below and presented as a graph, table and text information. Pacific Biosciences of California stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Pacific Biosciences of California …See Pacific Biosciences of California, Inc. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy.Nov 15, 2023 · Get Pacific Biosciences of California Inc (PACB.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Pacific Biosciences of California last issued its quarterly earnings results on October 30th, 2023. The biotechnology company reported ($0.27) earnings per share for the quarter, beating analysts' consensus estimates of ($0.29) by $0.02. The business earned $55.70 million during the quarter, compared to analyst estimates of $48.76 million.Pacific Biosciences. Pacific Biosciences of California, Inc. (aka PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. [2] [3] [failed verification] PacBio has two principal sequencing platforms: single-molecule real-time ... Pacific Biosciences of California Stock Earnings. The value each PACB share was expected to gain vs. the value that each PACB share actually gained. PACB ( PACB) reported Q3 2023 earnings per share (EPS) of -$0.26, beating estimates of -$0.29 by 9.37%. In the same quarter last year, PACB 's earnings per share (EPS) was -$0.34.

A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its trailing twelve months earnings. ... Pacific Biosciences of California rises after UBS upgrades on strong 'Revio ...Pacific Biosciences of California releases earnings for Q4 on February 16. 8 analysts are predicting losses of $0.360 per share compared to losses of $0.310 per share in the same quarter of the ...Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems.Pacific Biosciences' Q3 2023 highlighted the adoption of their Revio system, particularly among new customers. Read why PACB stock is a Buy.Oct. 30, 2023, 04:07 PM. (RTTNews) - Pacific Biosciences of California, Inc. (PACB) released Loss for third quarter that decreased from the same period last year and beat the Street estimates. The ...UBS Group upgraded shares of Pacific Biosciences of California (NASDAQ:PACB – Free Report) from a neutral rating to a buy rating in a research note issued to investors on Friday, Marketbeat.com reports. They currently have $10.00 price target on the biotechnology company’s stock, down from their previous price target of …

The stock of Pacific Biosciences of California (PACB 2.27%), a company developing DNA sequencing machines, is losing ground after an investor update. Preliminary fourth-quarter sales figures ...Nov 24, 2023 · Stock analysis for Pacific Biosciences of California Inc (PACB:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

PacBio Announces Third Quarter 2023 Financial Results. MENLO PARK, Calif. , Oct. 30, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2023 . Third quarter results Revenue of $55.7 million , a 72% increase compared with $32.3 million in the prior-year period. October 30, 2023.Find the latest Pacific Biosciences of California, Inc. (PACB) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. ١٦‏/٠٨‏/٢٠٢٣ ... Why Pacific Biosciences of California Inc's (PACB) Stock Is Down 4.55% ... One of the most dreaded feelings for an investor is when the stock they ...Pacific Biosciences of California (NASDAQ:PACB) rose 3.16% Friday pre-market after UBS upgraded the sequencing systems company on a strong "Revio" demand. ... The stock is currently trading at $7. ...Nov 19, 2023 · Pacific Biosciences of California Inc. (PACB) Stock Performance and Future Outlook in the Health Technology Sector. On November 19, 2023, Pacific Biosciences of California Inc. (PACB) had an eventful day in the stock market. PACB started the day with an opening price of $7.82, slightly higher than its previous closing price of $7.59. Jan-26-23 08:52AM. Pacific Biosciences of California (NASDAQ:PACB) shareholder returns have been massive, earning 313% in 5 years. (Simply Wall St.) Jan-24-23 11:18PM. Pacific Biosciences of California, Inc. Announces Pricing of Upsized Public Offering of Common Stock.

Pacific Biosciences of California (PACB) Q4 2021 Earnings Call Transcript PACB earnings call for the period ending December 31, 2021. Motley Fool Transcribing | Feb 16, 2022

Pacific Biosciences of California Inc. PACB (U.S.: Nasdaq) Pacific Biosciences of California Inc. View All companies. REAL TIME 12:47 PM EST 11/30/23. $8.62 USD.

Pacific Biosciences of California last issued its quarterly earnings results on October 30th, 2023. The biotechnology company reported ($0.27) earnings per share for the quarter, beating analysts' consensus estimates of ($0.29) by $0.02. The business earned $55.70 million during the quarter, compared to analyst estimates of $48.76 million.Traveling by car offers a sense of freedom and adventure that is hard to replicate with other modes of transportation. The Pacific Coast Highway, also known as Highway 1, stretches for over 600 miles along the stunning coastline of Californ...Pacific Biosciences of California has been profitable 1 over the past 10 years. Over the past twelve months, the company had a revenue of $146.10 million and Loss Per Share of $1.35.This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled ...٠٣‏/٠٤‏/٢٠٢١ ... Pacbio (Pacific Biosciences of California Inc) (Stock: PACB) CEO Christian Henry Interview on Business Outlook and Growth.Get the latest PACB stock quote, charts, news, and other financial information to help you make more informed trading and investment decisions. See the company's earnings, balance sheet, cash flow, and market cap for the second quarter of 2023.On average, Wall Street analysts predict. that Pacific Biosciences Of California's share price could reach $10.57 by Nov 17, 2024. The average Pacific Biosciences Of California stock price prediction forecasts a potential upside of …Investor Contact. Pacific Biosciences of California, Inc. 1305 O’Brien Drive, Menlo Park, CA 94025 [email protected] 27, 2023 · The average twelve-month price prediction for Pacific Biosciences of California is $11.80 with a high price target of $17.00 and a low price target of $8.00. Learn more on PACB's analyst rating history. Do Wall Street analysts like Pacific Biosciences of California more than its competitors?

Find the latest Pacific Biosciences of California, Inc. (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. Home. Mail; Search; News; Finance; ... Pacific Biosciences of California, Inc. (PACB) NasdaqGS - NasdaqGS Real-time price. Currency in USD. Add to watchlist. 8.88 +0.40 (+4.72%)Pacific Biosciences of California has been profitable 1 over the past 10 years. Over the past twelve months, the company had a revenue of $146.10 million and Loss Per Share of $1.35.Stock Price Forecast. The 12 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 10.50, with a high estimate of 19.00 and a low estimate of ... California’s mountains include many of the highest peaks in the country, including Mount Whitney, the highest summit in the contiguous United States. The state is home to numerous mountain ranges, including the many Pacific Coast Ranges and...Instagram:https://instagram. warren buffet lettersbuy amd stockwhat is the average cost of health insurance in georgiahp envy 6065e reviews Get the latest PACB stock quote, charts, news, and other financial information to help you make more informed trading and investment decisions. See the company's earnings, …PacBio Announces Third Quarter 2023 Financial Results. MENLO PARK, Calif. , Oct. 30, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2023 . Third quarter results Revenue of $55.7 million , a 72% increase compared with $32.3 million in the prior-year period. October 30, 2023. is legal and general life insurance goodstocks that are splitting KGI Securities started coverage on Pacific Biosciences of California and gave it an “outperform” rating in their report released on Wednesday June 7th. Morgan Stanley increased its price target for Pacific Biosciences of California from $12.00 to $13.00 and gave the stock an “equal weight” rating in their report on Thursday, August 3rd. forex book The Pacific Biosciences of California stock prediction results are shown below and presented as a graph, table and text information. Pacific Biosciences of California stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Pacific Biosciences of California analysts is $. Today ...The current consensus among the 12 polled investment analysts is to buy stock in Pacific Biosciences of California Inc. PACB reported earnings per share of -$0.30 for the current quarter and $53.0 million in sales for the same period. However, it is important to note that the financial data provided is as of February 14 and may not be the …